Immediate Impact
45 standout
Citing Papers
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
The role of technology in supply chain risk management: Innovations and challenges in logistics
2024 Standout
Works of Paul Sorenson being referenced
649. Developing FGFR4 Chimeric Antigen Receptor CAR T Cell Therapy Against Rhabdomyosarcoma
2016
Application framework issues when evolving business applications for electronic commerce
1999
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Paul Sorenson | 142 | 96 | 103 | 41 | 420 | |
| Seda Gürses | 213 | 49 | 262 | 26 | 499 | |
| Sebastian Pape | 75 | 52 | 177 | 34 | 384 | |
| Russell Boyatt | 73 | 23 | 117 | 21 | 512 | |
| Saad Zafar | 155 | 24 | 83 | 26 | 455 | |
| Travis D. Breaux | 214 | 36 | 292 | 44 | 505 | |
| Rebecca Balebako | 116 | 20 | 167 | 15 | 488 | |
| Michelle L. Mazurek | 80 | 47 | 332 | 45 | 488 | |
| Renate Motschnig-Pitrik | 82 | 63 | 121 | 39 | 418 | |
| Matteo Dell’Amico | 140 | 218 | 286 | 38 | 496 | |
| Peri Tarr | 194 | 103 | 202 | 21 | 473 |
All Works
Loading papers...